Oragenics
OGEN
15 hedge funds and large institutions have $3.1M invested in Oragenics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 14 → 15 (+1)
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less capital invested
Capital invested by funds: $6.46M → $3.1M (-$3.36M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$382K |
| 2 |
VF
Virtu Financial
New York
|
+$32.1K |
| 3 |
Renaissance Technologies
New York
|
+$27.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18.4K |
| 5 |
Barclays
London,
United Kingdom
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.74M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.37M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$10.1K |
| 4 |
GWMIA
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
|
-$1K |
OGEN Hedge Fund Activity: Q2 2019 in Review
15 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2019, worth a combined $3.1M — down 52% from $6.46M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $382K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.74M sold.
- 15 institutional investors held Oragenics (OGEN) as of Q2 2019, up from 14 in Q1 2019.
- Funds reported $3.1M of Oragenics stock for Q2 2019, down 52% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q2 2019 and 3 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q2 2019 was Sabby Management, an estimated $382K added.
- The largest Oragenics seller in Q2 2019 was Anson Funds Management, an estimated $1.74M sold.
Based on aggregated 13F filings for Q2 2019.